The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
4 2 Nicotinic Acetylcholine Receptors on Dopaminergic Neurons Mediate Nicotine Reward and Anxiety Relief
Open accessAbstract
Nicotine is the primary psychoactive substance in tobacco, and it exerts its effects by interaction with various subtypes of nicotinic acetylcholine receptors (nAChRs) in the brain. One of the major subtypes expressed in brain, the α4β2-nAChR, endogenously modulates neuronal excitability and thereby, modifies certain normal as well as nicotine-induced behaviors. Although α4-containing nAChRs are widely expressed across the brain, a major focus has been on their roles within midbrain dopaminergic regions involved in drug addiction, mental illness, and movement control in humans. We developed a unique model system to examine the role of α4-nAChRs within dopaminergic neurons by a targeted genetic deletion of the α4 subunit from dopaminergic neurons in mice. The loss α4 mRNA and α4β2-nAChRs from dopaminergic neurons was confirmed, as well as selective loss of α4β2-nAChR function from dopaminergic but not GABAergic neurons. Two behaviors central to nicotine dependence, reward and anxiety relief, were examined. α4-nAChRs specifically on dopaminergic neurons were demonstrated to be necessary for nicotine reward as measured by nicotine place preference, but not for another drug of addiction, cocaine. α4-nAChRs are necessary for the anxiolytic effects of nicotine in the elevated plus maze, and elimination of α4β2-nAChRs specifically from dopaminergic neurons decreased sensitivity to the anxiolytic effects of nicotine. Deletion of α4-nAChRs specifically from dopaminergic neurons also increased sensitivity to nicotine-induced locomotor depression; however, nicotine-induced hypothermia was unaffected. This is the first work to develop a dopaminergic specific deletion of a nAChR subunit and examine resulting changes in nicotine-related behaviors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, knockout of the α4 subunit abolishes intracerebroventricular (i.c.v.) selfadministration of nicotine, consistent with evidence that α4/β2 Ã nAChRs are required for depolarization of DA neurons in the VTA (Exley et al. 2011;McGranahan et al. 2011).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as McGranahan et al. 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, in mice with constitutive knockout of the α6 subunit, intra-VTA selfadministration of nicotine is not disrupted, whereas α4 Ã nAChRs are necessaryand sufficient for both intra-VTA self-administration, as well as nicotine-induced increases in firing of DA neurons (Exley et al. 2011;McGranahan et al. 2011).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as McGranahan et al. 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“particularly because the addictive effects of nicotine are mediated primarily through stimulation of nAChRs in the VTA (Drenan et al., 2008; Maskos et al., 2005; McGranahan et al., 2011; Picciotto et al., 1998).”
From Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior (2012) · cites this paper as McGranahan et al., 2011
Experimental — accuracy not yet measuredIn the citing paper
“mice lacking β2* nAChRs in dopamine neurons of the VTA lack anxiolytic responses to nicotine and are insensitive to nicotine reward (McGranahan et al., 2011)”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as McGranahan et al., 2011
In the citing paper
“Nicotine reinforcement and reward is mediated through nAChRs in the mesolimbic system (Maskos et al., 2005; McGranahan et al., 2011; Tolu et al., 2012)”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as McGranahan et al., 2011
In the citing paper
“McGranahan, Patzlaff, Grady, Heinemann, and Booker (2011) found that selective elimination of α4β2 nAChRs located on dopaminergic neurons reversed the anxiolytic effects of nicotine.”
From Nicotine addiction and psychiatric disorders (2015) · cites this paper as McGranahan et al. (2011)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307
Is there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1.
Sauer, B., & Henderson, N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5166 · Cited by 1,213
Pierce, R. C., & Kumaresan, V. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.016 · Cited by 913
Neuronal nicotinic receptors in the human brain
Paterson, D., & Nordberg, A. K. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00045-3 · Cited by 792
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740
Cited by
Sorted by citations
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.036 · Cited by 1,404
Injectable, Cellular-Scale Optoelectronics with Applications for Wireless Optogenetics
Kim, T.-I., McCall, J. G., Jung, Y. H., Huang, X., Siuda, E. R., Li, Y., Song, J., Song, Y. M., Pao, H. A., Kim, R.-H., et al. (2013) · Science · doi:10.1126/science.1232437 · Cited by 1,174
Moylan, S., Jacka, F. N., Pasco, J. A., & Berk, M. (2013) · Brain and Behavior · doi:10.1002/brb3.137 · Cited by 186
Molecular Mechanisms Underlying Behaviors Related to Nicotine AddictionPreprint
Picciotto, M. R., & Kenny, P. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012112 · Cited by 186
Mechanisms of Nicotine Addiction
Picciotto, M. R., & Kenny, P. J. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039610 · Cited by 161
Picciotto, M. R., Lewis, A. S., van Schalkwyk, G. I., & Mineur, Y. S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.028 · Cited by 157
Costas‐Ferreira, C., & Faro, L. R. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168413 · Cited by 156
Charbogne, P., Kieffer, B. L., & Befort, K. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.028 · Cited by 161
Nicotinic acetylcholine receptors in neuropathic and inflammatory pain
Hone, A. J., & McIntosh, J. M. (2017) · FEBS Letters · doi:10.1002/1873-3468.12884 · Cited by 135
Setti-Perdigão, P., Serrano, M. A. R., Flausino, O., Bolzani, V. D. S., Guimarães, M. Z. P., & Castro, N. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082726 · Cited by 125
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 134
Xiao, C., Zhou, C., Jiang, J., & Cui, Y. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0299-4 · Cited by 124
Molecules and circuits involved in nicotine addiction: The many faces of smoking
Picciotto, M. R., & Mineur, Y. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.028 · Cited by 123
Mechanisms and genetic factors underlying co-use of nicotine and alcohol or other drugs of abuse
Cross, S. J., Lotfipour, S., & Leslie, F. M. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1209512 · Cited by 101
Nicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders
Kutlu, M. G., & Gould, T. J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.029 · Cited by 97
Parikh, V., Kutlu, M. G., & Gould, T. J. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.020 · Cited by 97
Nicotinic acetylcholine receptors in neurological and psychiatric diseases
Terry, A. V., Jones, K., & Bertrand, D. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106764 · Cited by 90
Hancock, D. B., Reginsson, G. W., Gaddis, N. C., Chen, X., Saccone, N. L., Lutz, S. M., Qaiser, B., Sherva, R., Steinberg, S., Zink, F., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.149 · Cited by 85
Therapeutic Potential of 5-HT 2C Receptor Agonists for Addictive Disorders
Higgins, G. A., & Fletcher, P. J. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00025 · Cited by 85
Besson, M., & Forget, B. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00160 · Cited by 78
Sanjakdar, S. S., Maldoon, P. P., Marks, M. J., Brunzell, D. H., Maskos, U., McIntosh, J. M., Bowers, M. S., & Damaj, M. I. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.177 · Cited by 74
Nicotine addiction and psychiatric disorders
Kutlu, M. G., Parikh, V., & Gould, T. J. (2015) · International Review of Neurobiology · doi:10.1016/bs.irn.2015.08.004 · Cited by 65
Casarrubea, M., Davies, C., Faulisi, F., Pierucci, M., Colangeli, R., Partridge, L., Chambers, S., Cassar, D., Valentino, M., Muscat, R., et al. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00197 · Cited by 66
Nicotinic Receptor Contributions to Smoking: Insights from Human Studies and Animal Models
Brunzell, D. H., Stafford, A. M., & Dixon, C. I. (2015) · Current Addiction Reports · doi:10.1007/s40429-015-0042-2 · Cited by 58
Neurons and Glia Interplay in α-Synucleinopathies
Mavroeidi, P., & Xilouri, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094994 · Cited by 55
Anderson, S. M., & Brunzell, D. H. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13090 · Cited by 51
Nicotinic Cholinergic Receptors in VTA Glutamate Neurons Modulate Excitatory Transmission
Yan, Y., Peng, C., Arvin, M. C., Jin, X.-T., Kim, V. J., Ramsey, M. D., Wang, Y., Banala, S., Wokosin, D. L., McIntosh, J. M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.062 · Cited by 50
Nicotinic acetylcholine receptor (nAChR) mediated dopamine release in larval Drosophila melanogaster
Pyakurel, P., Shin, M., & Venton, B. J. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2017.12.012 · Cited by 45
Brunzell, D. H., McIntosh, J. M., & Papke, R. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12421 · Cited by 43
Haller, G., Kapoor, M., Budde, J., Xuei, X., Edenberg, H. J., Nürnberger, J. I., Kramer, J., Brooks, A., Tischfield, J. A., Almasy, L. A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt463 · Cited by 41
Anderson, S. M., & Brunzell, D. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048665 · Cited by 41
Chatterjee, S., Santos, N., Holgate, J. Y., Haass‐Koffler, C. L., Hopf, F. W., Kharazia, V., Lester, H. A., Bonci, A., & Bartlett, S. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068300 · Cited by 41
Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies
Ashok, A. H., Mizuno, Y., & Howes, O. D. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05196-1 · Cited by 36
Unraveling the neurobiology of nicotine dependence using genetically engineered mice
Stoker, A. K., & Markou, A. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.02.013 · Cited by 38
Treatment for Tobacco Dependence: Effect on Brain Nicotinic Acetylcholine Receptor Density
Brody, A. L., Mukhin, A. G., Shulenberger, S., Mamoun, M. S., Kozman, M., Phuong, J., Neary, M. K., Luu, T., & Mandelkern, M. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.53 · Cited by 33
Crucial Role of Dopamine D2 Receptor Signaling in Nicotine-Induced Conditioned Place Preference
Wilar, G., Shinoda, Y., Sasaoka, T., & Fukunaga, K. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1635-x · Cited by 34
Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area
Simonnet, A., Cador, M., & Caillé, S. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00476.x · Cited by 34
Brunzell, D. H. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts089 · Cited by 36
Casarrubea, M., Davies, C., Pierucci, M., Colangeli, R., Deidda, G., Santangelo, A., Aiello, S., Crescimanno, G., & Giovanni, G. D. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110131 · Cited by 29
Venom-Derived Neurotoxins Targeting Nicotinic Acetylcholine Receptors
Bekbossynova, A., Zharylgap, A., & Filchakova, O. (2021) · Molecules · doi:10.3390/molecules26113373 · Cited by 31
Moen, J. K., & Lee, A. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.745783 · Cited by 30
Zarrindast, M., Khalifeh, S., Rezayof, A., Rostami, P., Aghamohammadi‐Sereshki, A., & Zahmatkesh, M. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.036 · Cited by 33
Enhanced synthesis and release of dopamine in transgenic mice with gain‐of‐function α6* nAChR s
Wang, Y., Lee, J., Oh, G., Grady, S. R., McIntosh, J. M., Brunzell, D. H., Cannon, J. R., & Drenan, R. M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12616 · Cited by 31
Self-citationSensitization-dependent nicotine place preference in the adult zebrafish
Pisera-Fuster, A., Rocco, L., Faillace, M. P., & Bernabeu, R. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.02.018 · Cited by 29
Mitra, S., Mucha, M., Khatri, S., Glenon, R., Schulte, M. K., & Bult‐Ito, A. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00244 · Cited by 32
Nicotine and Cardiovascular Health: When Poison is Addictive – a WHF Policy Brief
Dorotheo, E. U., Arora, M., Banerjee, A., Bianco, E., Cheah, N. P., Dalmau, R., Eissenberg, T., Hasegawa, K., Naidoo, P., Nazir, N. T., et al. (2024) · Global Heart · doi:10.5334/gh.1292 · Cited by 34
Utility of genetically modified mice for understanding the neurobiology of substance use disorders
Fowler, C. D., & Kenny, P. J. (2011) · Human Genetics · doi:10.1007/s00439-011-1129-z · Cited by 30
Werner, F.-M., & Coveñas, R. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113206660280 · Cited by 27
McClure‐Begley, T. D., Papke, R. L., Stone, K. L., Stokes, C. A., Levy, A. D., Gelernter, J. E., Xie, P., Lindstrom, J. M., & Picciotto, M. R. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.209767 · Cited by 26
Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden
Gabriel, A. A., Atkins, J., Penha, R. C. C., Smith-Byrne, K., Gaborieau, V., Voegele, C., Abedi‐Ardekani, B., Milojevic, M., Olaso, R., Meyer, V., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac087 · Cited by 26
Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases
Bye, L. J., Finol‐Urdaneta, R. K., Tae, H., & Adams, D. J. (2023) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2023.106387 · Cited by 28
Sharp, B. M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13970 · Cited by 25
Mazzaferro, S., Whiteman, S. T., Alcaino, C., Beyder, A., & Sine, S. M. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03592-x · Cited by 24
Morud, J., Strandberg, J., Andrén, A., Ericson, M., Söderpalm, B., & Adermark, L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.002 · Cited by 24
Hussmann, G. P., DeDominicis, K. E., Turner, J. R., Yasuda, R. P., Klehm, J., Forcelli, P. A., Xiao, Y., Richardson, J. R., Sahibzada, N., Wolfe, B. B., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12653 · Cited by 23
Caruso, M. J., Reiss, D. E., Caulfield, J. I., Thomas, J. L., Baker, A. N., Cavigelli, S. A., & Kamens, H. M. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.08.001 · Cited by 23
Tobey, K. M., Walentiny, D. M., Wiley, J. L., Carroll, F. I., Damaj, M. I., Azar, M. R., Koob, G. F., George, O., Harris, L. S., & Vann, R. E. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2703-3 · Cited by 23
Effect of varenicline on aspects of inhibitory control in smokers
Austin, A. J., Duka, T., Rusted, J. M., & Jackson, A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3512-7 · Cited by 23
Neurochemical binding profiles of novel indole and benzofuran MDMA analogues
Shimshoni, J. A., Winkler, I., Golan, E., & Nutt, D. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1297-4 · Cited by 23
Multidimensional Intersection of Nicotine, Gene Expression, and Behavior
Sherafat, Y., Bautista, M. R., & Fowler, C. D. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.649129 · Cited by 25
Peng, C., Stokes, C. A., Mineur, Y. S., Picciotto, M. R., Tian, C., Eibl, C., Tomassoli, I., Guendisch, D., & Papke, R. L. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.206904 · Cited by 21
Mohammadi, S. A., Burton, T. J., & Christie, M. J. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.005 · Cited by 23
Takechi, K., Suemaru, K., Kiyoi, T., Tanaka, A., & Araki, H. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.02.021 · Cited by 21
Nebrisi, E. E., Lozon, Y., & Öz, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073210 · Cited by 20
Mitra, S., Khatri, S. N., Maulik, M., Bult-Ito, A., & Schulte, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144918 · Cited by 21
Nagy, P. M., & Aubert, I. (2013) · Brain and Behavior · doi:10.1002/brb3.139 · Cited by 21
Jiang, J. W., Li, X., Hu, A., Zhou, G., Gao, Y.-H., Xu, C., Wu, X., & Wang, H. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1670883 · Cited by 24
Nicotinic Receptors Underlying Nicotine Dependence: Evidence from Transgenic Mouse Models
Gipson, C. D., & Fowler, C. D. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_134 · Cited by 19
Guy, E. G., Fisher, D. C., Higgins, G. A., & Fletcher, P. J. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000092 · Cited by 17
Gözen, O., Nesil, T., Kanıt, L., Koylu, E. O., & Pöğün, Ş. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1198799 · Cited by 17
Repeated nicotine vapor inhalation induces behavioral sensitization in male and female C57BL/6 mice
Honeycutt, S. C., Garrett, P. I., Barraza, A. G., Maloy, A. N., & Hillhouse, T. M. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000562 · Cited by 16
Hawkins, R. D. (2013) · Learning & Memory · doi:10.1101/lm.031237.113 · Cited by 17
Rodriguez, J. S., Cunningham, C. S., de Moura, F. B., Ondachi, P. W., Carroll, F. I., & McMahon, L. R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3589-z · Cited by 15
Nicotine levels after IV nicotine and cigarette smoking in men.
Mello, N. K., Peltier, M. R., & Duncanson, H. (2013) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0031799 · Cited by 16
Genetic matters: Thirty years of progress using mouse models in nicotinic research
Marks, M. J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.021 · Cited by 13
Goutier, W., Kloeze, M. B., & McCreary, A. C. (2013) · Addiction Biology · doi:10.1111/adb.12108 · Cited by 15
Tarren, J. R., Lester, H. A., Belmer, A., & Bartlett, S. E. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00338 · Cited by 16
Zhang, C., Beebe, N. L., Schofield, B. R., Pecka, M., & Burger, R. M. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1633-20.2020 · Cited by 12
The interpeduncular nucleus blunts the rewarding effect of nicotine
Jehl, J., Ciscato, M., Vicq, É., Guyon, N., de la Bâtie, G. D., Mondoloni, S., Frangieh, J., Mohayyaei, M., Nguyen, C., Pons, S., et al. (2023) · Neuron · doi:10.1016/j.neuron.2025.03.035 · Cited by 12
Cambiaghi, M., Grosso, A., Renna, A., Concina, G., & Sacchetti, B. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.036 · Cited by 11
Mantione, M. E., Micheloni, S., Alcaino, C., New, K., Mazzaferro, S., & Bermúdez, I. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.172 · Cited by 12
Altered nicotine reward-associated behavior following α4 nAChR subunit deletion in ventral midbrain
Peng, C., Engle, S. E., Yan, Y., Weera, M. M., Berry, J. N., Arvin, M. C., Zhao, G., McIntosh, J. M., Chester, J. A., & Drenan, R. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182142 · Cited by 14
Association of CHRNA5 Gene Variants with Crack Cocaine Addiction
Aroche, A. P., Rovaris, D. L., Grevet, E. H., Stolf, A. R., Sanvicente‐Vieira, B., Kessler, F. H. P., DIEMEN, L. V., Grassi‐Oliveira, R., Bau, C. H. D., & Schuch, J. B. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08596-1 · Cited by 12
New medications development for smoking cessation
Lengel, D., & Kenny, P. J. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100103 · Cited by 14
Impact of Maternal Nicotine Exposure on Expression of Myelin-Related Genes in Zebrafish Larvae
Zhao, S., Cui, W.-Y., Cao, J., Luo, C., Fan, L., & Li, M. D. (2013) · Zebrafish · doi:10.1089/zeb.2013.0889 · Cited by 11
Forcelli, P. A., Turner, J. R., Lee, B. G., Olson, T. T., Xie, T., Xiao, Y., Blendy, J. A., & Kellar, K. J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.012 · Cited by 11
Neurobiology of Stress-Induced Nicotine Relapse
Wang, X., Chen, Y., Dong, J., Ge, J., Liu, X., & Liu, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031482 · Cited by 10
Palumbo, T. B., & Miwa, J. M. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106845 · Cited by 11
Storage, S. S., Mandelkern, M. A., Phuong, J., Kozman, M., Neary, M. K., & Brody, A. L. (2013) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2013.07.010 · Cited by 10
Noda, Y., Uchida, M., Mouri, A., Yamada, S., Goto, S., Kitagaki, S., Mamiya, T., Kushima, I., Arioka, Y., Ozaki, N., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.10.001 · Cited by 10
Isotani, R., Igarashi, M., Miura, M., Naruse, K., Kuranami, S., Katoh, M., Nomura, S., & Yamauchi, T. (2024) · eLife · doi:10.7554/elife.95267 · Cited by 10
Structural bases for stoichiometry‐selective calcium potentiation of a neuronal nicotinic receptor
Mazzaferro, S., Kang, G., Natarajan, K., Hibbs, R. E., & Sine, S. M. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16321 · Cited by 8
Zhang, L., Zhang, X. P., Chen, Y. Q., & Ye, W.-X. (2015) · Genetics and Molecular Research · doi:10.4238/2015.may.12.14 · Cited by 10
Rusali, L. E., Lopez-Hernandez, A. M., Kremiller, K. M., Kulkarni, G., Gour, A., Straub, C. J., Argade, M. D., Peters, C. J., Sharma, A., Toll, L., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01758 · Cited by 7
Stoichiometry‐selective modulation of α4β2 nicotinic ACh receptors by divalent cations
Mazzaferro, S., Strikwerda, J. R., & Sine, S. M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15723 · Cited by 8
Sanchez, M. E., Quadir, S. G., Whindleton, C. M., Hoffman, J. L., Faccidomo, S., Lee, T. N. G., Cr, E., Hodge, C. W., & Herman, M. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109676 · Cited by 8
TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors
Wall, T. R., Henderson, B. J., Voren, G., Wageman, C. R., Deshpande, P., Cohen, B. N., Grady, S. R., Marks, M. J., Yohannes, D., Kenny, P. J., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00641 · Cited by 8
Self-citationGender differences in the relationship between nicotine exposure and symptoms of depression
Liu, Y., Zhang, L., Fu, S., Wei, S., Jin, Z., & He, L. R. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173857 · Cited by 7
Characterization of a novel oronasal-restricted nicotine vaping self-administration model in mice
Akinola, L. S., Buzzi, B., Kalck, E., Le, K., Klein, S., Vaughn, J., Basir, J., Poklis, J. L., Whiteaker, P., Shelton, K. L., et al. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110315 · Cited by 6
Stratilov, V. A., Vetrovoy, O. V., Potapova, S., & Tyulkova, E. I. (2024) · Neuroendocrinology · doi:10.1159/000536214 · Cited by 6
Metadata
- Authors
- McGranahan, T. M., Patzlaff, N. E., Grady, S. R., Heinemann, S. F., & Booker, T. K.
- Affiliations
- Salk Institute for Biological Studies (US)
- University of Colorado Boulder (US)
- ORCID
- McGranahan, T. M.
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2011-07-27
- Volume
- 31
- Issue
- 30
- Pages
- 10891-10902
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC3539812
- OpenAlex
- W1973295491
- Cited by
- 165
- References
- 60
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 20 · 2023: 12 · 2022: 4 · 2021: 9 · 2020: 12 · 2019: 5 · 2018: 3 · 2017: 9 · 2016: 10 · 2015: 17 · 2014: 14 · 2013: 21 · 2012: 9
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA13018, R01AA013018)
- National Institute on Drug Abuse (DA018247, R01DA018247, DA012242, R01DA003194, DA003194, R01DA012242)
- National Institute of Neurological Disorders and Stroke (NS10830, F32NS010830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nicotinic acetylcholine receptors, alpha4beta2 nAChR, dopaminergic neurons, nicotine reward, nicotine dependence, midbrain dopaminergic system, cocaine reward
- MeSH terms
- Analysis of Variance, Animals, Anxiety, Behavior, Animal, Body Temperature, Conditioning, Operant, Disease Models, Animal, Dopamine, Female, gamma-Aminobutyric Acid, Glutamate Decarboxylase, Male, Mesencephalon, Mice, Inbred C57BL, Neurons, Nicotine, Protein Binding, Pyridines, Receptors, Nicotinic, Reward, Synaptosomes, Tritium, Mice, Knockout, Nicotinic Agonists, Bridged Bicyclo Compounds, Heterocyclic, Dopamine Plasma Membrane Transport Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
